Melt Pharmaceuticals, Inc. (MELT)

Melt Pharmaceuticals was planning to go public, but the IPO was withdrawn on Jan 4, 2023.
Stock Price: Pending
IPO price not available yet
Chart not available yet
Data will show when the stock starts trading.
Market Cap n/a
Revenue (ttm) n/a
Net Income (ttm) -10.24M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About MELT

Melt is a clinical stage pharmaceutical company focused on the development and commercialization of proprietary non-opioid, non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient and in-office settings. We intend to seek regulatory approval through the FDA’s 505(b)(2) regulatory pathway for these proprietary, patented small-molecule product candidates, where possible. The core intellectual property we own is a patented series of combination non-opioid sedation drug formulations that we believe have mul... [Read more]

Industry Health Care
Sector Pharmaceuticals
Founded 2019
Employees 3
Stock Exchange NASDAQ
Ticker Symbol MELT
Full Company Profile

Financial Performance

Financial Statements


Melt Pharmaceuticals IPO Registration Document (S-1)

Melt Pharmaceuticals has filed to go public with an IPO on the NASDAQ.

1 year ago - SEC